Model validity for preclinical studies in precision medicine: precisely how precise do we need to be?
Ontology highlight
ABSTRACT: The promise of personalized medicine is that each patient's treatment can be optimally tailored to their disease. In turn, their disease, as well as their response to the treatment, is determined by their genetic makeup and the "environment," which relates to their general health, medical history, personal habits, and surroundings. Developing such optimized treatment strategies is an admirable goal and success stories include examples such as switching chemotherapy agents based on a patient's tumor genotype. However, it remains a challenge to apply precision medicine to diseases for which there is no known effective treatment. Such diseases require additional research, often using experimentally tractable models. Presumably, models that recapitulate as much of the human pathophysiology as
SUBMITTER: Tadenev ALD
PROVIDER: S-EPMC6606658 | biostudies-literature | 2019 Jun
REPOSITORIES: biostudies-literature
ACCESS DATA